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Proper activation followed by inactivation of 
immune responses is essential for the mainte-
nance of immunological homeostasis in vivo. 
Prolonged or aberrant activation of immune re-
sponses cause a variety of immunopathological 
disorders, which often result in tissue destruc-
tion mediated by eff  ector cells and cytokines.
We and others have found that IL-15 is 
a pivotal cytokine for the development and 
function of innate immune cells, including NK 
cells, NKT cells, TCRγδ+ intestinal intraepi-
thelial lymphocytes, and DCs (1–9). IL-15 also 
aff   ects the acquired immune system because 
the proliferation and survival of CD8+ T cells 
with naive and memory phenotypes, as well 
as antigen-specifi  c memory CD8+ T cells, are 
impaired in both IL-15Rα−/− and IL-15−/− 
mice (4, 6, 10–12). These studies showed a 
benefi  cial eff  ect of IL-15 on the establishment 
and maintenance of the immune system against 
pathogen infections as well as malignancies.
In contrast, circumstantial evidence sug-
gests that IL-15 is also involved in the develop-
ment of immunopathological disorders. IL-15 
mRNA and protein are expressed in synovial 
membranes in rheumatoid arthritis (RA) (13, 
14). It has been suggested that IL-15 precedes 
TNF-α production in cytokine cascade to re-
cruit T cells into the synovial membranes, pos-
sibly contributing to the pathogenesis of RA 
(13, 14). Supporting this notion, treatment of 
DBA/1 mice with the soluble IL-15Rα and 
IL-15 mutant/Fcγ2a fusion protein, which 
bind the IL-15R with high affi   nity but do not 
trigger signaling events, prevents the mice from 
developing collagen-induced arthritis (15, 16). 
The elevated numbers of IL-15–expressing 
cells and/or elevated levels of IL-15 produc-
tion correlate with the activities of infl  amma-
tory bowel disease (17), type C chronic liver 
disease (18), sarcoidosis (19), and multiple scle-
rosis (20). These observations suggest a harmful 
eff  ect of IL-15 in various immunopathological 
and infl  ammatory diseases. However, as IL-15 
is produced by many cell types, it remains un-
known whether development of these diseases 
attributes to DC-derived IL-15.
In this study we generated new mAbs to 
detect and block mouse IL-15 activity and 
established an ELISA system that enabled us 
to examine the amounts of IL-15 at protein 
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Interleukin (IL)-15 is expressed in a variety of infl  ammatory diseases. However, the contri-
bution of dendritic cell (DC)–derived IL-15 to the development of diseases is uncertain. 
Using established models of Propionibacterium acnes (P. acnes)– and zymosan-induced liver 
infl  ammation, we observed granuloma formation in the livers of wild-type (WT) and RAG-
2−/− mice but not in those of IL-15−/− mice. We demonstrate that this is likely caused by 
an impaired sequential induction of IL-12, IFN-𝗄, and chemokines necessary for monocyte 
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both systems, proinfl  ammatory cytokine production was impaired. Surprisingly, neither 
granuloma formation, lethal endotoxin shock, nor IL-15 production was induced in mice 
defi  cient for DCs, and adoptive transfer of WT but not IL-15−/− DCs restored the disease 
development in IL-15−/− mice. Collectively, these data indicate the importance of DC-derived 
IL-15 as a mediator of infl  ammatory responses in vivo.
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level. Using the mAb and ELISA system combined with 
gene-  targeted mice, we investigated the role of IL-15 in 
well-characterized infl  ammatory disease models in mice. 
We demonstrate that IL-15 is essential for P. acnes– and 
  zymosan-induced granuloma formation and subsequent LPS-
induced endotoxin shock, as well as liver damage, through 
induction of proinfl  ammatory cytokines and chemokines. 
Of interest, the development of liver diseases and endo-
toxin shock is unaff  ected in the absence of T, B, and NK 
cells, whereas it was severely aff  ected in mice lacking DC-
derived IL-15. These experiments identify an irreplaceable 
function of DC-derived IL-15 in bacterial product–mediated 
  infl  ammatory responses.
RESULTS
Impaired granuloma formation in IL-15−/− mice
P. acnes is suspected to be a causative bacteria for human sar-
coidosis, and its cell wall components show strong immuno-
adjuvant activities, which induce monocyte migration into 
the liver and granuloma formation (21–23).
To examine the role of IL-15 in the granuloma formation 
in vivo, control WT and IL-15−/− mice were injected with 
heat-killed P. acnes. Consistent with previous reports (21–23), 
granuloma formation was evident in the liver of WT mice on 
day 6 after injection, whereas it was hardly seen in that of IL-
15−/− mice (Fig. 1 A, top left and top middle). Importantly, 
the granuloma formation was substantially restored by IL-15 
injection into IL-15−/− mice (Fig. 1 A, top right). It has been 
reported that on P. acnes infection circulating DC precursors 
migrate into the liver and, in cooperation with Kupff  er cells, 
monocytes, and T cells, participate in the granulomatous 
  reaction (24). Indeed, P. acnes–induced granulomas contained 
CD11c+ DCs (Fig. 1 B). The granuloma formation was ob-
served in the liver of RAG-2−/− mice and NK cell–depleted 
RAG-2−/− mice but was absent in that of IL-15−/−RAG-
2−/− mice (Fig. 1 A, bottom; and Fig. S1, available at 
Figure 1.  IL-15−/− mice fail to develop P. acnes– and zymosan-
induced granulomas. (A) Granuloma formation in the liver of WT, 
IL-15−/−, RAG-2−/−, and IL-15−/−RAG-2−/− mice. Livers were taken on 
day 6 after a 0.5-mg heat-killed P. acnes injection, and sections were 
stained with H&E. Bar, 100 μm. (B) The liver sections of P. acnes–injected 
WT and IL-15−/− mice were stained with biotinylated anti-CD11c mAb 
and streptavidin-HRP and further visualized with DAB. Slides were coun-
terstained with Mayer’s hematoxylin. Bar, 100 μm. (C) Chemokine levels 
in the sera of WT, IL-15−/−, RAG-2−/−, and IL-15−/−RAG-2−/− mice were 
assessed by ELISA at 72 h after a 0.5-mg heat-killed P. acnes injection. 
Values represent SD (n = 3 mice/group). Data are representative of two 
to four experiments. (D) Granuloma formation in the liver of zymosan-
injected WT and IL-15−/− mice. Livers were taken on day 6 after a 1 mg 
zymosan injection, and sections were stained with biotinylated anti-
CD11c mAb and streptavidin-HRP and further visualized with DAB. Slides 
were counterstained with Mayer’s hematoxylin. Bar, 100 μm. (E) The liver 
sections of P. acnes–injected WT and IFN-γ−/− mice were stained as de-
scribed in B. Bar, 100 μm. (F) 3 d after a 1-mg zymosan injection, CCL2 in 
the sera of WT and IL-15−/− mice was measured by ELISA. Data are repre-
sentative of four experiments. (G) 3 d after a 0.5-mg P. acnes injection, 
IL-12p70, and IFN-γ in the sera of WT and IL-15−/− mice and CCL2 in the 
sera of WT and IFN-γ−/− mice were measured by ELISA. Values represent 
SD (n = 3 mice/group). Data are representative of three experiments.JEM VOL. 203, October 2, 2006  2331
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http://www.jem.org/cgi/content/full/jem.20061297/DC1), 
indicating that both T, B, and NK cells are dispensable in the 
process of granuloma formation. Because chemokine produc-
tion is critical for monocyte migration into the liver, we next 
examined the chemokine production, in particular MCP-1 
(CCL2) and MIP-1α/β (CCL3/4), which are critical che-
moattractants for  monocytes. On day 3 after P. acnes injection, 
considerable levels of these chemokines were detected in the 
sera of WT, RAG-2−/−, and NK cell–depleted RAG-2−/− 
mice (Fig. 1 C and Fig. S2, available at http://www.jem.
org/cgi/content/full/jem.20061297/DC1). In contrast, these 
chemokines were produced only marginally in IL-15−/− and 
IL-15−/−RAG-2−/− mice (Fig. 1 C). Again, the chemokine 
production was restored by IL-15 injection into IL-15−/− 
mice. To further examine whether IL-15 directly controls 
the chemokine production, we analyzed IFN-γ−/− mice. As 
reported previously (23), P. acnes–induced granuloma forma-
tion was not seen in the liver of IFN-γ−/− mice (Fig. 1 E). 
In addition, we found that P. acnes–induced IL-12p70 and 
IFN-γ production in IL-15−/− and CCL2 production in 
IFN-γ−/− mice was impaired (Fig. 1 G), indicating that 
IL-15 indirectly induces chemokine production by regulat-
ing the IL-12–IFN-γ axis in vivo.
Zymosan is a yeast cell wall particle containing β-glucan 
and mannan as major components. As P. acnes does, zymosan 
can activate and recruit monocytes, macrophages, and leu-
kocytes (25–27), resulting in the secretion of infl  ammatory 
cytokines, hydrogen peroxide, and arachidonic acid (28–30). 
We also used zymosan to examine the role for IL-15 in the 
granuloma formation. Consistent with previous experiments 
(31), zymosan recruited monocytes and DCs and induced 
granuloma formation in the liver of WT mice. Again, the 
granulomas were not seen in the liver of IL-15−/− mice 
(Fig. 1 D), likely because of the lack of chemokine produc-
tion, such as CCL2 (Fig. 1 F) (31). Our results collectively 
indicate that IL-15 controls P. acnes– and zymosan-induced 
granuloma formation, likely through the regulation of che-
mokine production in vivo.
IL-15 regulates LPS-induced lethal endotoxin shock
LPS injection into P. acnes–primed mice stimulates DCs and 
macrophages to produce large amounts of proinfl  ammatory 
cytokines such as IL-12, IFN-γ, and TNF-α, which cause 
lethal endotoxin shock in vivo (32–34). Likewise, LPS in-
jection into zymosan-primed mice induces shock and tissue 
injury (35). We next examined the role of IL-15 in LPS-
induced endotoxin shock. On day 6 after a 0.5-mg heat-
killed P. acnes injection, 1 μg LPS was injected into WT 
and IL-15−/− mice to induce lethal endotoxin shock. As 
reported (32–34), P. acnes–primed WT mice were sensitive 
to LPS-induced endotoxin shock, and all mice died within 
a day. In contrast, IL-15−/− mice were strongly resistant 
and survived (Fig. 2 A). In addition, NK cell–  depleted 
WT mice, RAG-2−/−, mice and NK cell–  depleted RAG-
2−/− mice died just as control WT mice did, indicating 
that proinfl   ammatory cytokines produced by T, B, and 
NK cells are dispensable for the endotoxin shock induction 
(Fig. 2 A).
IL-12, IFN-γ, and TNF-α are known to play impor-
tant roles in induction of liver injury and/or endotoxin 
shock (23, 34, 36–39). We thus examined the production of 
proinfl  ammatory cytokines, in particular IL-12p70, IFN-γ, 
and TNF-α, in control WT and IL-15−/− mice (Fig. 2 B). 
Shortly after LPS injection (2 h), these cytokines were de-
tected in the sera of control WT mice, whereas only small 
amounts of these cytokines were produced in the sera of IL-
15−/− mice (Fig. 2 B). Because these cytokines cause liver in-
jury, the level of serum glutamic-pyruvic transaminase (GPT) 
and glutamic-oxaloacetic transaminase (GOT), an index for 
hepatocyte damage, was also measured. As expected from the 
Figure 2.  IL-15−/− mice are resistant to LPS-induced lethal endo-
toxin shock. (A) On day 6 after a 0.5-mg heat-killed P. acnes injection, 
1 μg LPS were further injected into the indicated mice to induce lethal 
endotoxin shock. To deplete NK cells, mice were intraperitoneally injected 
with 300 μg of anti-asialo GM1 polyclonal antibody on the day before 
and day 3 after P. acnes injection. (B) Serum levels of IL-12p70, IFN-γ, and 
TNF-α were measured by ELISA in P. acnes–primed mice at 2 h after LPS 
injection. Values represent SD (n = 3 WT and 2 IL-15−/− mice/group). 
Data are representative of three experiments. (C) Serum GOT and GPT 
levels were assessed in P. acnes–primed mice at 2 h after LPS injection. 
Values represent SD (n = 3 mice/group). Data are representative of two to 
four experiments. (D) On day 6 after a 1-mg zymosan injection, 10 μg LPS 
was injected into the indicated mice, and the survival of the mice was 
monitored. (E) Serum levels of IL-12p70, IFN-γ, and TNF-α were measured 
by ELISA in zymosan-primed mice at 2 h after LPS injection. Values repre-
sent SD (n = 3 mice/group). Data are representative of three experiments.2332  ROLE OF DC-DERIVED IL-15 IN INFLAMMATORY RESPONSES | Ohteki et al.
minimal proinfl  ammatory cytokine production,   considerable 
reduction of GPT and GOT release was observed in the 
sera of IL-15−/− mice, as compared with those in WT mice 
(Fig. 2 C). Similar to these observations, zymosan-primed 
IL-15−/− mice exhibited strong resistance to LPS-induced 
lethality, which was consistent with the reduced production 
of IL-12, IFN-γ, and TNF-α (Fig. 2, D and E).
Unaffected DC survival in IL-15−/− mice
As recently reported that IL-15 regulates survival of DCs 
(40), impaired infl  ammatory responses observed in IL-15−/− 
mice might be caused by the impaired DC survival. To ex-
amine this possibility, we examined the number of splenic 
DCs between WT and IL-15−/− mice before and after 
P. acnes injection. The numbers of DCs in untreated WT and 
IL-15−/− mice were 0.83 × 106 ± 0.15 (n = 5) and 0.82 × 
106 ± 0.13 (n = 5), respectively, and those in P. acnes–  injected 
WT and IL-15−/− mice (6 d after injection) were 1.39 × 
106 ± 0.28 (n = 4) and 1.54 × 106 ± 0.16 (n = 4),  respectively. 
Using annexin V and propidium iodide staining, we further 
analyzed the number of apoptotic DCs before and after 
P. acnes injection and found no important diff  erence between 
WT and IL-15−/− DCs (Fig. 3). These results suggested that 
impaired infl  ammatory responses observed in IL-15−/− mice 
are unlikely caused by the impaired DC survival in vivo.
mAb generation to detect and block mouse IL-15 activity
As IL-15 was found to be a critical mediator for granuloma 
formation and endotoxin shock induction in vivo, it is im-
portant to quantitate the amount of IL-15 produced as a sol-
uble protein in mice during the induction phase of granuloma 
formation and the eliciting phase of endotoxin shock. For 
this purpose, we generated rat mAbs specifi  c for mouse IL-15 
(for details see Materials and methods). Among 108 clones, 2 
clones named AIO2 and AIO3 produced mAbs against mouse 
IL-15, which were suitable as coating antibodies for an ELISA 
system. Importantly, the newly developed ELISA system is 
specifi  c for mouse IL-15 and does not cross react with other 
cytokines tested, which include IL-2, IL-4, IL-12, TNF-α, 
IFN-α, IFN-β, IFN-γ, and GM-CSF (Fig. 4 A). Using the 
ELISA system, we found that substantial amounts of IL-15 
were produced in the sera of P. acnes–injected WT mice, and 
the IL-15 levels were dramatically enhanced immediately 
  after LPS injection into P. acnes–primed WT mice (Fig. 4 B), 
Figure 3.  Unaffected apoptosis in IL-15−/− DCs. Splenic DCs were 
obtained from NK cell–depleted WT and IL-15−/− mice before (untreated) 
and 1 d (P. acnes, d1) and 6 d (P. acnes, d6) after heat-killed P. acnes injec-
tion. (A and B) The proportions of annexin V+ DCs of WT and IL-15−/− 
mice are shown. (C and D) The proportions of propidium iodide–positive 
DCs of WT and IL-15−/− mice are shown. Values represent SD (n = 2 
mice/group). Data are representative of three experiments.
Figure 4.  Quantifi  cation of IL-15 protein levels by ELISA and 
treatment of endotoxin shock by IL-15 neutralizing antibody. 
(A) Newly generated ELISA was specifi  c for mouse IL-15. Specifi  city of one 
anti–IL-15 mAb (AIO3) was tested by using the panel of cytokines indi-
cated in the fi  gure. (B) Detection of IL-15 protein in the sera of P. acnes– 
and LPS-injected WT mice. Serum samples were collected from WT and 
IL-15−/− mice on days 2 and 5 after P. acnes injection and at 1.5 h after a 
subsequent LPS injection on day 6, and levels of IL-15 were assessed with 
our IL-15 ELISA system. Values represent SD (n = 3 mice/group). Data are 
representative of two to four experiments. (C) To test the capacity of AIO2 
and AIO3 to block IL-15 activities, 5 × 104 CTLL-2 cells were stimulated 
with 10 ng/ml IL-15 or IL-2 in the presence or absence of 10 μg/ml AIO2 
or AIO3 for 24 h and pulsed with [3H]thymidine for an additional 8 h. 
Values represent SD of triplicate cultures. Data are representative of two 
to four experiments. (D) To examine whether AIO2 can block IL-15 activi-
ties in vivo, WT mice were injected with 0.5 mg AIO2 either on day 0, 3, or 
6 (x3 AIO2) or only on day 6 (x1 AIO2) after P. acnes injection. On day 6, 
1 h after AIO2 injection, 1 μg LPS was further injected, and survival of 
these mice was monitored.JEM VOL. 203, October 2, 2006  2333
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which was consistent with the observation that the lack of 
IL-15 resulted in the impaired endotoxin shock.
The results shown in Fig. 2 (A and D) and Fig. 4 B collec-
tively raised a possibility of treatment of infl  ammatory diseases 
by blocking IL-15 activity in vivo. To this end, we examined 
whether anti–IL-15 mAbs were capable of blocking IL-15 
activity (Fig. 4 C). It is well known that both IL-2 and IL-15 
effi   ciently induce proliferation of a T cell line, CTLL-2. As 
shown in Fig. 4 C, IL-15–dependent proliferation of CTLL-2 
was markedly reduced (>95% reduction) in the presence of 
AIO2 or AIO3, whereas IL-2–dependent proliferation of 
CTLL-2 was not aff  ected at all by these mAbs, demonstrating 
that the mAbs effi   ciently and selectively block IL-15 activity 
in vitro. We further examined the eff  ect of AIO2 in vivo 
(Fig. 4 D). WT mice that had been injected with AIO2 on 
days 0, 3, and 6 after P. acnes injection (x3 AIO2) and only 
on day 6 (1 h before LPS injection, x1 AIO2) were strongly 
resistant to LPS-induced lethality and survived. The results 
Figure 5.  DC-derived IL-15 controls granuloma formation. 
(A) Spleen cells were obtained from DTR tg mice 24 h after injection of 
100 ng DT or PBS and stained with anti-CD11c–PE. The percentages indi-
cate the proportions of DCs in a DC-enriched fraction; i.e., the cells at the 
interface after a dense BSA gradient centrifugation (see DC preparation... 
in Materials and methods). (B) Granuloma formation in the liver of 
P. acnes–primed DT-injected DTR tg mice. On day 3 after a 0.5-mg heat-
killed P. acnes injection, livers were taken from WT and DTR tg mice that 
had been injected with either PBS or DT on the day before P. acnes injec-
tion, and sections were stained with H&E. Numbers of granulomas were 
counted in fi  ve different fi  elds under a microscope. Values represent SD 
(n = 3 mice/group). Data are representative of three experiments. (C) To 
test whether DCs were present in the granuloma regions, the liver sec-
tions were stained with biotinylated anti-CD11c mAb and streptavidin-
HRP and further visualized with DAB. Slides were counterstained with 
Mayer’s hematoxylin. Bar, 100 μm. (D) IL-12p70, IFN-γ, and chemokine 
levels in the sera of DT-injected DTR tg mice were assessed by ELISA at 
72 h after a 0.5-mg heat-killed P. acnes injection. Values represent SD 
(n = 3 mice/group). Data are representative of three experiments. 
(E) Immunofl  uoresence staining for the identifi  cation of IL-15–producing 
cells. Acetone-fi  xed frozen tissue sections were incubated with FITC-
  conjugated anti-CD11c (clone N418) and biotinylated anti–IL-15 antibod-
ies and further developed with streptavidin-PE. Bar, 50 μm. (F) Granuloma 
formation in the liver of zymosan-primed DT-injected DTR tg mice. As 
described in B and C, livers were taken from the indicated mice on day 3 
after a 1-mg zymosan injection, and sections were stained for CD11c. 
Slides were counterstained with Mayer’s hematoxylin. Bar, 100 μm. 
(G) Granuloma formation in the liver of BMDC-injected IL-15−/− mice. 
IL-15−/− mice were injected with 1 × 106 WT BMDCs or IL-15−/− BMDCs. 
After 12 h, mice were injected with 0.5 mg P. acnes, and granuloma for-
mation was analyzed 6 d later as described in B, C, and F. Bar, 100 μm.2334  ROLE OF DC-DERIVED IL-15 IN INFLAMMATORY RESPONSES | Ohteki et al.
clearly show that antibody capable of neutralizing IL-15 acti-
vity is eff  ective in blocking endotoxin shock in vivo.
Essential roles for DC-derived IL-15 in infl  ammatory 
response induction
As DCs are present in granuloma regions (Fig. 1, B, D, and 
E), we further examined the role of DCs in the granuloma 
formation using CD11c–diphtheria toxin receptor (DTR)–
GFP transgenic (DTR tg) mice (41). Because the mice carry 
a transgene encoding DTR-GFP fusion protein under the 
control of a mouse CD11c promoter, DT injection induces 
selective depletion of DCs in vivo (Fig. 5 A) (41). P. acnes– 
and zymosan-induced (Fig. 5, B and C; and Fig. 5 F, respec-
tively) granulomas were observed in the livers of untreated 
WT, DT-injected WT, and untreated DTR tg mice, as ex-
pected. In contrast, neither CD11c+ DCs nor granulomas 
themselves were observed in the DT-injected DTR tg mice 
(Fig. 5, B, C, and F). Consistent with this observation, pro-
duction of IL-12p70, IFN-γ, CCL2, and CCL3/4 was im-
paired in the DT-injected DTR tg mice, as observed in 
IL-15−/− mice (Fig. 5 D). Importantly, immunohistochemi-
cal analysis revealed that many IL-15–producing cells in 
granuloma regions were CD11c+ DCs (Fig. 5 E). Contrary 
to the case of IL-15−/− mice, however, IL-15 administration 
restored neither the P. acnes–induced granulomatous liver 
disease nor CCL2 production in DC-depleted DTR tg mice 
(Fig. 5, B and D), implying that direct action of DC-derived 
IL-15 on DCs is necessary for the chemokine-mediated gran-
uloma formation in vivo. To formally demonstrate the im-
portance of DC-derived IL-15 in the granuloma formation, 
BM-derived DCs (BMDCs) of WT and IL-15−/− mice were 
adoptively transferred into IL-15−/− mice. Importantly, the 
granuloma formation was substantially restored by the injec-
tion of WT but not IL-15−/− BMDCs into IL-15−/− mice 
(Fig. 5 G), demonstrating that DC-derived IL-15 is essential 
for the granuloma formation.
Intracellular redox status aff  ects the pattern of cytokine 
production by DCs and macrophages (42–45). For example, 
reductive DCs (and macrophages) with elevated intracellu-
lar glutathione (GSH) preferentially produce IL-12 and are 
involved in Th1 responses, whereas oxidative DCs with re-
duced GSH produce IL-10 and PGE2, which lead to Th2 
cell induction. As P. acnes priming effi   ciently  induces  re-
ductive status in DCs (44), we next examined the role for 
IL-15 in determining redox status in DCs (Fig. S3, available 
at http://jem.org.cgi/content/full/jem.20061297/DC1). As 
previously shown (44), P. acnes injection clearly induced a 
reductive condition with elevated intracellular GSH levels 
in WT DCs. In contrast, such a reductive condition was not 
induced, if any, in IL-15−/− DCs on P. acnes stimulation. 
These data indicate that IL-15 is one of the critical cytokines 
in reductive DC diff  erentiation.
We also examined the role of DCs in endotoxin shock. 
1 d after DT injection, control WT and DTR tg mice were 
primed with 0.5 mg P. acnes. On day 3 after P. acnes injection, 
these mice were injected with 1 μg LPS, and survival rate was 
monitored. On LPS injection, all P. acnes–primed WT and 
DT-untreated DTR tg mice died of endotoxin shock within 
24 h (Fig. 6 A). However, P. acnes–primed and DT-injected 
DTR tg mice survived much longer than control mice, in-
dicating that DCs play a pivotal role in endotoxin shock as 
well. Of note, DT-injected DTR tg mice survived relatively 
shorter than IL-15−/− mice (Fig. 2 A), which was likely be-
cause of the gradual recovery of DCs in DT-injected DTR 
tg mice as reported previously (41). P. acnes–primed DT-
  injected DTR tg mice showed impaired production of IL-15 
and IL-15–regulated proinfl  ammatory cytokines, IL-12p70, 
IFN-γ, and TNF-α on LPS stimulation (Fig. 6 B). In addi-
tion, WT BMDC-transferred IL-15−/− mice became sensi-
tive to the endotoxin shock, and all mice died within a day, 
whereas IL-15−/− BMDC–injected IL-15−/− mice remained 
resistant (Fig. 6 C). Collectively, these results indicate that 
DC-derived IL-15 is critical for endotoxin shock induction 
in vivo.
Figure 6.  DC-derived IL-15 regulates endotoxin shock. (A) 1 d 
after DT injection, control WT and DTR tg mice were primed with 0.5 mg 
P. acnes. On day 3 after P. acnes injection, these mice were further in-
jected with 1 μg LPS, and survival rate was monitored. (B) Serum levels 
of IL-15, IL-12p70, IFN-γ, and TNF-α were assessed in DT-injected and 
P. acnes–primed DTR tg mice at 2 h after LPS injection. Values represent 
SD (n = 3 mice/group). Data are representative of three experiments. 
(C) IL-15−/− mice were injected with 1 × 106 WT or IL-15−/− BMDCs. 
After 12 h, mice were injected with 0.5 mg P. acnes. On day 6 after 
P. acnes injection, these mice were further injected with 5 μg LPS, and 
survival rate was monitored.JEM VOL. 203, October 2, 2006  2335
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DISCUSSION
DC-derived IL-15
Prolonged or aberrant activation of immune responses cause 
a variety of immunopathological disorders that are often me-
diated by eff  ector cells and cytokines. We previously found 
that DC-derived IL-15 is required for the functional matura-
tion of DCs, such as IL-12 production in response to LPS and 
agonistic anti-CD40 mAb combined with IL-4 stimulation 
in vitro (8), and have recently shown that DC-derived IL-15 
is essential for CpG-induced protective immune activation 
against pathogen infections in vivo (9). In contrast to the 
benefi  cial eff  ect of DC-derived IL-15, we maintain in this 
study that DC-derived IL-15 has harmful aspects and causes 
infl  ammatory diseases, such as granuloma formation and en-
dotoxin shock in vivo.
IL-15 is involved in a variety of infl  ammatory and auto-
immune diseases (13, 14, 17-20). To address whether de-
velopment of these diseases attributes to IL-15, analyses 
using IL-15−/− mice, anti–IL-15 neutralizing antibody, 
soluble IL-15Rα, and IL-15 mutant/Fcγ2a fusion protein 
are in progress in both human and mouse models (15, 16). 
As IL-15 is produced by multiple cell types, which include 
DCs, macrophages, monocytes, and endothelial cells (5), an 
advanced and unresolved question has been whether DC-
derived IL-15 is exclusively required for the development of 
certain diseases in vivo. Numerous previous in vitro stud-
ies indicated that DC-derived IL-15 is capable of inducing 
activation of Th1 cells, CTL, NK cells, monocyte diff  er-
entiation into DCs, and antigen-processing machinery in 
DCs (5, 46), but these studies did not directly prove the 
irreplaceable role of DC-derived IL-15 in disease develop-
ment in vivo, where multiple IL-15 producers are present. 
To address this issue, it is important to show that the devel-
opment of certain diseases is impaired in IL-15−/− or WT 
mice treated with reagents to block IL-15 activity, and to 
further restore the disease development by adoptively trans-
ferring WT but not IL-15−/− DCs into these mice. In this 
respect, only one paper has shown that IL-15−/− or WT 
mice treated with soluble IL-15Rα were impaired in CD8+ 
T cell  –dependent delayed-type hypersensitivity response, 
and the delayed-type hypersensitivity response was restored 
by injecting antigen-labeled WT DCs in vivo (47). It is un-
clear, however, whether IL-15 is important for cytokine 
production or antigen presentation in this study (47). Other 
groups have shown that IL-15Rα and IL-15 expression by 
hematopoietic cells is critical for the maintenance of anti-
gen-specifi  c memory CD8+ T cells and bystander CD8+ 
T cell proliferation through a “transpresentation” pathway 
(48–53), and implied DCs as the major source of IL-15 but 
never proved it.   Accordingly, it remains unknown whether 
DC-derived IL-15 is essential in the maintenance of innate 
and acquired immune responses, and whether it causes in-
fl  ammatory disease development in vivo. It is thus important 
to prove the in vivo role of DC-derived IL-15 for the devel-
opment of antiinfl  ammatory drugs that selectively block the 
DC-  derived IL-15 activity.
Mechanisms of how IL-15 controls cytokine production 
are unknown. As shown in this paper, IL-15 increased the 
intracellular GSH levels in DCs. Intracellular GSH levels in 
DCs and macrophages play an important role in determin-
ing the profi  les of proinfl  ammatory cytokines (42–45). We 
have previously demonstrated that reductive DCs with high 
intracellular GSH levels preferentially produce IFN-γ, which 
in turn augment GSH levels in the cells (44). As shown in 
this paper, IL-15 is also one of the positive regulators of in-
tracellular GSH status in DCs, augmenting the production 
of proinfl  ammatory cytokines. In future studies, it should be 
determined how IL-15 controls the amounts of intracellular 
GSH in DCs.
Granuloma formation, liver injury, and IL-15
The number of P. acnes–induced granulomas and LPS-in-
duced hepatic necrosis after priming with P. acnes are substan-
tially reduced in IFN-γ−/− mice (Fig. 1 E) (23). In addition, 
P. acnes does not induce granuloma formation in TNF-RI−/− 
mice and mice treated with soluble TNF-RI (21). These stud-
ies clearly demonstrate the importance of IFN-γ and TNF-α 
in P. acnes–induced liver diseases in vivo. In contrast, it has 
been shown that CCL3 attracts DC precursors in the blood 
into the sinusoidal granuloma and lets them participate in in-
fl  ammatory responses in P. acnes–primed mice (24). In addi-
tion, CCL2 has also been reported as an important monocyte 
chemoattractant for granuloma models induced by zymosan, 
P. acnes, and Mycobacterium tuberculosis (54–56). These studies 
show that the chemokines play a critical role in granuloma 
models, though the importance of IFN-γ and TNF-α in 
chemokine production remains unclear. Notably, we deter-
mined that an IL-15–IL-12–IFN-γ–chemokine (CCL2/3/4) 
axis in innate immune system is essential, whereas T and B 
cells are dispensable for the development of granulomatous 
disease and/or liver injury. Immunohistochemical analysis re-
vealed that DCs preferentially expressed IL-15 in the granu-
loma regions, and the granuloma formation was impaired in 
mice lacking DC and DC-derived IL-15 production, clearly 
demonstrating that DC-derived IL-15 is an initiator for the 
development of liver diseases.
Of note, IL-15 injection restored the granuloma forma-
tion in the liver of IL-15−/− mice but not DC-depleted DTR 
tg mice. These results suggest that a critical fi  rst step for the 
granuloma formation is to stimulate DCs with DC-derived 
IL-15 in an autocrine manner. Although Kupff  er cells are 
critically involved as initial antigen-presenting (P. acnes and 
zymosan) cells (24), Kupff   er cells isolated from P. acnes–
primed mice were unable to produce IL-15 on LPS stimula-
tion in vitro (unpublished data).
Endotoxin shock and IL-15
LPS-induced liver injury is closely coupled to endotoxin 
shock. Indeed, mice defi  cient in IL-12, IFN-γ, TNF-α, or 
the receptors for these cytokines displayed resistance to LPS-
induced endotoxin shock (34, 36, 38, 57). We showed in 
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  DC-derived IL-15 controls endotoxin shock induction by 
controlling the production of IL-12, IFN-γ, and TNF-α, 
as DC-depleted mice produced these cytokines at much re-
duced levels, and WT DC-injected IL-15−/− mice became 
sensitive to endotoxin shock. Contrary to IL-15−/− mice, 
P. acnes–primed IL-18−/− mice showed much higher TNF-α 
production and susceptibility to LPS-induced endotoxin 
shock (58). Together with our results, IL-15 and IL-18 func-
tion apparently through distinct pathways in terms of TNF-α 
production, and IL-15 induces, whereas IL-18 suppresses, 
TNF-α production.
Collectively, we propose here that DC-derived IL-15 is a 
master regulator of infl  ammatory responses in granulomatous 
liver diseases and related endotoxin shock. Indeed, DC-
  derived IL-15 regulates the production of IL-12p70, IFN-γ, 
TNF-α, and downstream CCL2/3/4. Given that elevated 
IL-15 production and IL-15–expressing cells are evident in 
RA (13, 14), infl  ammatory bowel disease (17), type C chronic 
liver disease (18), sarcoidosis (19), multiple sclerosis (20), and 
celiac disease (59), it is important to further investigate the 
roles of IL-15 in these infl  ammatory diseases and search for 
the propriety of IL-15 as a target for the development of an-
tiinfl  ammatory drugs.
MATERIALS AND METHODS
Mice. B6–IL-15−/− (IL-15−/−) mice (6) were purchased from Taconic, 
and B6-RAG2−/− (RAG2−/−) mice were provided by Taconic and Central 
Laboratories for Experimental Animals. B6–IFN-γ−/− mice were purchased 
from The Jackson Laboratory. To obtain B6–IL-15−/−RAG2−/− mice 
(IL-15−/− × RAG2−/−), F1 mice were backcrossed with RAG2−/− mice, 
and the obtained IL-15+/−RAG2−/− mice were intercrossed. The off  spring 
were genotyped for IL-15, and IL-15−/−RAG2−/− mice were used for ex-
periments. B6-CD11c-DTR-GFP mice (41) were provided by Steff  en Jung, 
Dan R. Littman, and Richard A. Lang (New York University School of 
Medicine, New York, NY). All mice were maintained in our specifi  c patho-
gen-free animal facility, and experiments were performed between 6–12 wk 
of age in accordance with the guidelines of the Institutional Animal Care 
Committee of Akita University and Keio University School of Medicine.
Histologic and immunohistochemical analysis. Frozen livers embed-
ded in OCT compound (Sakura Finetek) were sliced into 5-μm-thick sec-
tions and fi   xed with 1% paraformaldehyde and stained with Mayer’s 
hematoxylin and eosin (H&E). Sections of livers were observed with a mi-
croscope (DM4500 B; Leica). For CD11c immunostaining, acetone-fi  xed 
5-μm fresh-frozen tissue sections were incubated with biotinylated anti-
CD11c mAb (clone, N418; eBioscience) overnight at 4°C and with strepta-
vidin-conjugated horseradish peroxidase (HRP; PerkinElmer). Sections 
were immunostained using 3,3′-diaminobenzidine (DAB) substrate liquid 
(DakoCytomation). Slides were counterstained with Mayer’s hematoxylin. 
For CD11c and IL-15 double immunofl  uorescence staining, acetone-fi  xed 
5-μm fresh-frozen tissue sections were incubated with FITC-conjugated 
anti-CD11c (clone, N418; eBioscience) and biotinylated goat anti–mouse 
IL-15 polyclonal antibody (R&D Systems) for 1 h at room temperature. 
Sections were further stained with streptavidin-conjugated PE (eBioscience) 
for 30 min at room temperature and observed by fl  uorescence microscopy.
Measurement of serum chemokines, cytokines, GPT, and GOT. 
Levels of IL-12p70, IFN-γ, TNF-α, and CCL2/3/4 in the sera were mea-
sured by ELISA kits (IL-12p70, IFN-γ, and TNF-α were obtained from BD 
Biosciences; CCL2/3/4 was obtained from R&D Systems), according to the 
manufacturer’s instructions. The concentrations of cytokines were deter-
mined using a data analysis program (Softmax PRO; Molecular Devices). 
Serum GPT and GOT levels were determined with Fuji Dri-Chem 5500V 
(Fuji Medical System), according to the manufacturer’s instructions.
Generation of anti–mouse IL-15 mAb and ELISA for mouse IL-15. 
To detect mouse IL-15 protein, mAbs specifi  c for mouse IL-15 were gen-
erated by immunizing mouse IL-15 into Lewis rat. Using conventional 
methods, spleen cells isolated from the immunized rat were fused with 
X63-Ag8.653 myeloma cells, and limiting dilution for hybridoma cells was 
  performed. Positive clones producing anti–IL-15 mAb were screened based 
on the binding capacity to coated mouse IL-15. Among the mAbs, AIO2 
and AIO3 clones were further selected as neutralizing mAbs based on the 
inhibition of IL-15–dependent CTLL-2 cell proliferation. In brief, 5 × 104 
CTLL-2 cells were cultured with 10 ng/ml IL-15 or IL-2 in the presence or 
absence of 10 μg/ml AIO2 and AIO3 for 24 h and pulsed with [3H]thymidine 
for an additional 8 h. For mouse IL-15 sandwich ELISA, microwells were 
coated with AIO3 overnight at 4°C and incubated with Block Ace (Dainip-
pon Pharmaceutical) for 90 min. The diluted serum samples were incubated 
for 2 h, then for 60 min with biotinylated goat anti–mouse IL-15 antibody 
(R&D Systems) and for 60 min with avidin  -HRP (Sigma-Aldrich). The 
absorbance of substance released from the substrate was measured at 450 nm. 
The IL-15 concentrations in samples were determined using Softmax PRO, 
based on a standard curve of recombinant mouse IL-15.
Reagents and in vivo treatment. Mice were injected with either 0.5 mg 
of heat-killed P. acnes (American Type Culture Collection) or 1 mg of zy-
mosan (Sigma-Aldrich). 6 d later, the amounts of LPS indicated in the fi  gures 
(Escherichia coli O55:B5; Sigma-Aldrich) were further injected into P. acnes– 
and zymosan-primed mice, respectively, to induce endotoxin shock. To 
deplete NK cells, 300 μg/200 μl of polyclonal anti-asialo GM1 (Wako) 
was injected. To neutralize IL-15 in vivo, 0.5 mg AIO2 was injected. For 
systemic DC depletion in vivo, CD11c-DTR-GFP mice were injected 
  intraperitoneally with 100 ng/body of diphtheria toxin (Sigma-Aldrich).
DC preparation, detection of apoptosis, and adoptive transfer. DCs 
were prepared from spleens as previously described (8). In brief, collagenase-
digested spleen cells were suspended in a 28% BSA solution in 1.08 g/ml 
PBS, overlaid with 1 ml FCS-free RPMI 1640 medium (Sigma-Aldrich), 
and centrifuged at 9,500 g for 20 min at 4°C. The cells at the interface were 
collected, washed, and resuspended. DCs were further purifi  ed using anti-
CD11c (clone N418) microbeads with an autoMACS separation system 
(Miltenyi Biotec). To detect apoptotic DCs, 5 × 105 DCs were cultured in 
vitro for 6 h and incubated for 15 min at room temperature in 500 μl an-
nexin V binding buff  er with 150 ng/ml annexin V (R&D Systems) or for 
10 min at 4°C in 500 μl PBS with 2 μg/ml propidium idodide (Sigma-
  Aldrich), respectively. For generation of BMDCs, WT and IL-15−/− BM 
cells were cultured at 1.5 × 106 cells/ml in 10% FCS RPMI 1640 medium 
in the presence of 10 ng/ml GM-CSF (RDI Division of Fitzgerald Indus-
tries). After 3 d of culture, half of the medium was exchanged with a fresh 
one. After 6 d of culture, BMDCs were purifi  ed using anti-CD11c micro-
beads with an   autoMACS separation system. For adoptive transfer experi-
ments, 1 × 106   BMDCs were intravenously injected into IL-15−/− mice.
Qualitative determination of intracellular GSH with ACAS. The 
procedures have previously been described (44). In brief, 300 μl of a suspen-
sion of splenic DCs, adjusted to a density of 3 × 105 cells/ml in an RPMI 
1640 (phenol red free) medium, were applied into a chamber slide (Lab-
Tek; Nunc) and incubated for 3 h. After washing, 300 μl of 10 μM mono-
chlorobiman was added, and the reaction was conducted for 30 min. The 
fl  uorescence intensity was monitored by argon-ion laser cytometry with a 
workstation (ACAS 570; Meridian Instruments). Intracellular GSH levels 
were detected with an excitation wavelength of 350 nm and an emission 
wavelength of 460 nm.
Online supplemental material. Fig. S1 shows granuloma formation in 
the liver of NK cell–depleted RAG-2−/− mice. Fig. S2 shows the level of JEM VOL. 203, October 2, 2006  2337
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serum CCL2 in NK cell–depleted RAG-2−/− mice. Fig. S3 shows reductive 
status in P. acnes–stimulated IL-15−/− DCs.
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